<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> is the most common cause of <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">Infectious Mononucleosis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Nearly <z:hpo ids='HP_0000001'>all</z:hpo> adult humans harbor life-long, persistent <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> which can lead to development of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> including Hodgkin <z:hpo ids='HP_0002665'>Lymphoma</z:hpo>, Burkitt <z:hpo ids='HP_0002665'>Lymphoma</z:hpo>, nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp>, gastric <z:mp ids='MP_0002038'>carcinoma</z:mp>, and <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in immunosuppressed patients </plain></SENT>
<SENT sid="2" pm="."><plain>BARF1 is an EBV replication-associated, secreted protein that blocks Colony Stimulating Factor 1 (CSF-1) signaling, an innate immunity pathway not targeted by any other virus species </plain></SENT>
<SENT sid="3" pm="."><plain>To evaluate effects of BARF1 in <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:e sem="disease" ids="C1264606" disease_type="Disease or Syndrome" abbrv="">persistent infection</z:e>, we mutated the BARF1 homologue in the EBV-related herpesvirus, or lymphocryptovirus (LCV), naturally infecting rhesus macaques to create a recombinant rhLCV incapable of blocking CSF-1 (ΔrhBARF1) </plain></SENT>
<SENT sid="4" pm="."><plain>Rhesus macaques orally challenged with ΔrhBARF1 had decreased <z:mp ids='MP_0001799'>viral</z:mp> load indicating that CSF-1 is important for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0042769" disease_type="Disease or Syndrome" abbrv="">virus infection</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Surprisingly, ΔrhBARF1 was also associated with dramatically lower virus setpoints during <z:e sem="disease" ids="C1264606" disease_type="Disease or Syndrome" abbrv="">persistent infection</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0001799'>viral</z:mp> load and <z:mpath ids='MPATH_458'>normal</z:mpath> <z:mp ids='MP_0001799'>viral</z:mp> setpoints during persistent rhLCV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> could be restored by Simian/Human <z:hpo ids='HP_0002721'>Immunodeficiency</z:hpo> Virus-induced immunosuppression prior to oral inoculation with ΔrhBARF1 or <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> of immunocompetent animals with a recombinant rhLCV where the rhBARF1 was repaired </plain></SENT>
<SENT sid="7" pm="."><plain>These results indicate that BARF1 blockade of CSF-1 signaling is an important immune evasion strategy for efficient <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> and a significant determinant for virus setpoint during persistent <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> </plain></SENT>
</text></document>